• I-BET151 (GSK1210151A): Technical Guide for Cancer Assays

  2026-04-27

  I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor used to modulate transcriptional responses in cancer research, especially in apoptosis and cell cycle arrest assays. It is best suited for laboratory workflows targeting BRD2, BRD3, and BRD4 pathways; however, it should not be used for diagnostic or clinical applications.

• Species-Specific Metabolism of HD56: Insights from Humanized

  2026-04-26

  This study demonstrates that the carboxylate ester prodrug HD56 exhibits superior pharmacokinetics and species-specific metabolic conversion compared to its active metabolite HD561, with humanized mice serving as a highly predictive model for human drug metabolism. These findings highlight the critical role of humanized animal models in translational drug research and the rational design of ester prodrugs targeting FK506 binding proteins.

• Fluorinated-Sorbitol Polyplexes Advance mRNA Vaccine Deliver

  2026-04-25

  This study introduces fluorinated-sorbitol modified polyplexes (PFS) for mRNA delivery, enhancing both cellular uptake and endosomal escape. The dual-modality system achieves efficient mRNA vaccination in preclinical models, offering a promising alternative to lipid nanoparticles.

• FCCP Accelerates Mitochondrial Biology Research in Cancer St

  2026-04-24

  FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) redefines experimental workflows in mitochondrial and immunometabolic research through precise control of oxidative phosphorylation uncoupling. This article details optimized protocols, advanced use-cases, and troubleshooting strategies for leveraging FCCP in inhibition of HIF pathways and metabolic regulation studies.

• Budesonide: Applied Strategies for Anti-Inflammatory Assays

  2026-04-24

  Harnessing Budesonide’s potent anti-inflammatory corticosteroid profile, this article translates cutting-edge permeability modeling and biomimetic assay workflows into actionable steps for respiratory disease research. With data-backed troubleshooting and parameter optimization, researchers can achieve reproducible, high-sensitivity insights—grounded in peer-reviewed innovations and APExBIO’s rigorous product standards.

• Nicotine Aggravates CKD Progression: Mechanisms and Implicat

  2026-04-23

  This review by Jain and Jaimes synthesizes clinical and experimental evidence on nicotine’s role in accelerating chronic kidney disease (CKD) progression in smokers. The paper highlights the contribution of non-neuronal nicotinic acetylcholine receptors, oxidative stress, and pro-fibrotic pathways, calling attention to the potential for targeted mechanistic studies and novel intervention strategies.

• N3-kethoxal Enables Advanced RNA Structure and DNA Mapping

  2026-04-23

  N3-kethoxal, a cutting-edge azide-functionalized probe from APExBIO, empowers researchers to probe RNA secondary structures and map accessible DNA with unmatched selectivity—even in live cells. This guide connects reference-driven insights with hands-on troubleshooting and protocol optimization for robust, reproducible results.

• Caspase-8 Fluorometric Assay Kit: Decoding Apoptosis Pathway

  2026-04-22

  Discover how the Caspase-8 Fluorometric Assay Kit enables precise measurement of cysteine-dependent aspartate-directed protease activity. Explore novel insights from recent cancer therapy research and gain practical guidance for advanced programmed cell death investigations.

• Rotigotine hydrochloride: Precision Dopamine D2/D3 Agonist A

  2026-04-22

  Rotigotine hydrochloride is a full dopamine D2/D3 receptor agonist with validated neuroprotective, antiparkinsonian, and antidepressant effects. Its robust affinity profile and diverse delivery methods support advanced Parkinson's disease and dopaminergic signaling research. APExBIO provides high-purity Rotigotine hydrochloride (A3777) for reproducible workflows.

• EZ Cap™ Human PTEN mRNA: Transforming Tumor Suppressor Studi

  2026-04-21

  EZ Cap™ Human PTEN mRNA enables precise, high-efficiency restoration of PTEN function, unlocking robust cancer research and gene therapy workflows. Its Cap 1 structure and poly(A) tail deliver superior mRNA stability and translational output, setting the standard for reproducible PI3K/Akt pathway modulation.

• Applied Research with (-)-Arctigenin: Precision as a MEK1 In

  2026-04-21

  (-)-Arctigenin sets itself apart as a high-purity, multi-modal MEK1 inhibitor and iNOS expression regulator, empowering researchers to dissect NF-κB and MAPK/ERK signaling in advanced cancer and neuroprotection studies. Learn how optimized workflows, robust troubleshooting, and direct translation of recent breast cancer findings maximize reproducibility and insight.

• ABT-888 (Veliparib): Assay Optimization and Resistance Insig

  2026-04-20

  Uncover the advanced use of ABT-888 (Veliparib) in DNA repair inhibition assay design with a focus on resistance mechanisms, assay parameters, and translational implications for colorectal and MSI tumor research.

• Metoprolol: Selective Beta1-Adrenoceptor Antagonist for Rese

  2026-04-20

  Metoprolol is a selective beta1-adrenoceptor antagonist widely used in cardiovascular disease research. It enables precise modulation of sympathetic signaling and exhibits anti-inflammatory, anti-tumor, and anti-angiogenic properties, supporting advanced experimental designs.

• Pentraxin 3 Counters Glucocorticoid-Induced Femoral Head Nec

  2026-04-19

  This study reveals that pentraxin 3 (PTX3) mitigates glucocorticoid-induced osteonecrosis of the femoral head by modulating the TLR4/NF-κB/FGF21 axis. The findings highlight a novel mechanistic pathway and suggest new avenues for therapeutic intervention targeting ER stress and related bone degeneration.

• Maternal Deltamethrin Exposure Impairs Offspring Memory via

  2026-04-18

  This study demonstrates that prenatal and early postnatal exposure to deltamethrin disrupts hippocampal-dependent learning and memory in male rats by triggering p53-mediated ferroptosis. The findings clarify the molecular link between environmental neurotoxins and neurodevelopmental impairment, suggesting potential intervention points for future research.

462 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page